Background: Plasmodium falciparum EBA175 and PfRh2 belong to two main families involved in parasite invasion, and both are potential vaccine candidates. Current knowledge is limited regarding which target antigens and subclasses of antibodies are actually important for protection, and how naturally acquired immunity is achieved.

Methods: Repeated blood samples were collected from individuals in Nigeria over a period of almost one year. ELISA was used to analyse subclasses of IgG responses.

Results: For both EBA175 (region III-V) and (a fragment of) PfRh2, the dominant antibody responses consisted of IgG1 and IgG3 followed by IgG2, while for PfRh2 there was also a relatively prominent response for IgG4. High levels of IgG1, IgG2 and IgG3 for EBA175 and total IgG for PfRh2 correlated significantly with a lower parasitaemia during the study period. Children with HbAS had higher levels of some subclasses compared to children with HbAA, while in adults the pattern was the opposite. The half-lives of IgG2 and IgG4 against EBA175 were clearly shorter than those for IgG1 and IgG3.

Conclusion: EBA175 and PfRh2 are potential targets for protective antibodies since both correlated with lower parasitaemia. The shorter half-lives for IgG2 and IgG4 might explain why these subclasses are often considered less important in protection against malaria. Triggering the right subclass responses could be of critical importance in a successful vaccine. Further studies are needed to evaluate the role of haemoglobin polymorphisms and their malaria protective effects in this process.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232678PMC
http://dx.doi.org/10.1186/1475-2875-13-425DOI Listing

Publication Analysis

Top Keywords

eba175 pfrh2
12
subclass responses
8
naturally acquired
8
acquired immunity
8
plasmodium falciparum
8
correlated lower
8
lower parasitaemia
8
half-lives igg2
8
igg2 igg4
8
eba175
6

Similar Publications

Article Synopsis
  • Understanding the functional characteristics of naturally acquired antibodies against P. falciparum merozoite antigens is essential for assessing their protective roles.
  • A study in Nigeria used Surface Plasmon Resonance (SPR) to measure the stability of antibody affinities against EBA175 and PfRh2, revealing that many individuals maintained stable affinities over time, with PfRh2 showing higher affinity overall.
  • Results indicated that younger individuals produced similar or more potent antibodies than adults for EBA175, and there was a strong correlation between antibody affinity for PfRh2 and its ability to inhibit merozoite invasion, highlighting important insights into antibody responses to malaria.
View Article and Find Full Text PDF

Erythrocyte-binding antigens (EBAs) and P. falciparum reticulocyte-binding homologue proteins (PfRhs) are two important protein families that can vary in expression and utilization by P. falciparum to evade inhibitory antibodies.

View Article and Find Full Text PDF

Background: Plasmodium falciparum EBA175 and PfRh2 belong to two main families involved in parasite invasion, and both are potential vaccine candidates. Current knowledge is limited regarding which target antigens and subclasses of antibodies are actually important for protection, and how naturally acquired immunity is achieved.

Methods: Repeated blood samples were collected from individuals in Nigeria over a period of almost one year.

View Article and Find Full Text PDF

Blood-stage malaria vaccines that target single Plasmodium falciparum antigens involved in erythrocyte invasion have not induced optimal protection in field trials. Blood-stage malaria vaccine development has faced two major hurdles, antigenic polymorphisms and molecular redundancy, which have led to an inability to demonstrate potent, strain-transcending, invasion-inhibitory antibodies. Vaccines that target multiple invasion-related parasite proteins may inhibit erythrocyte invasion more efficiently.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!